Venus Concept (VERO) Competitors $2.45 +0.02 (+0.82%) Closing price 08/22/2025 04:00 PM EasternExtended Trading$2.44 -0.01 (-0.41%) As of 08/22/2025 05:49 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERO vs. NXL, MHUA, TNON, XAIR, LYRA, OSRH, INBS, CODX, POAI, and LUCYShould you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include Nexalin Technology (NXL), Meihua International Medical Technologies (MHUA), Tenon Medical (TNON), Beyond Air (XAIR), Lyra Therapeutics (LYRA), OSR (OSRH), Intelligent Bio Solutions (INBS), Co-Diagnostics (CODX), Predictive Oncology (POAI), and Innovative Eyewear (LUCY). These companies are all part of the "medical equipment" industry. Venus Concept vs. Its Competitors Nexalin Technology Meihua International Medical Technologies Tenon Medical Beyond Air Lyra Therapeutics OSR Intelligent Bio Solutions Co-Diagnostics Predictive Oncology Innovative Eyewear Nexalin Technology (NASDAQ:NXL) and Venus Concept (NASDAQ:VERO) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, dividends, risk, profitability, institutional ownership and earnings. Is NXL or VERO more profitable? Venus Concept has a net margin of -68.77% compared to Nexalin Technology's net margin of -5,057.14%. Nexalin Technology's return on equity of -209.20% beat Venus Concept's return on equity.Company Net Margins Return on Equity Return on Assets Nexalin Technology-5,057.14% -209.20% -186.87% Venus Concept -68.77%-871.77%-61.92% Which has stronger valuation & earnings, NXL or VERO? Nexalin Technology has higher earnings, but lower revenue than Venus Concept. Nexalin Technology is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNexalin Technology$170K104.52-$7.61M-$0.76-1.34Venus Concept$60.11M0.06-$47M-$50.78-0.05 Does the media refer more to NXL or VERO? In the previous week, Venus Concept had 1 more articles in the media than Nexalin Technology. MarketBeat recorded 1 mentions for Venus Concept and 0 mentions for Nexalin Technology. Nexalin Technology's average media sentiment score of 0.00 equaled Venus Concept'saverage media sentiment score. Company Overall Sentiment Nexalin Technology Neutral Venus Concept Neutral Which has more volatility and risk, NXL or VERO? Nexalin Technology has a beta of 3.69, suggesting that its share price is 269% more volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.12, suggesting that its share price is 88% less volatile than the S&P 500. Do institutionals and insiders hold more shares of NXL or VERO? 0.7% of Nexalin Technology shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 25.3% of Nexalin Technology shares are owned by insiders. Comparatively, 28.0% of Venus Concept shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Do analysts rate NXL or VERO? Nexalin Technology currently has a consensus target price of $5.00, indicating a potential upside of 390.20%. Given Nexalin Technology's stronger consensus rating and higher probable upside, research analysts clearly believe Nexalin Technology is more favorable than Venus Concept.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nexalin Technology 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Venus Concept 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 SummaryNexalin Technology beats Venus Concept on 8 of the 15 factors compared between the two stocks. Get Venus Concept News Delivered to You Automatically Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VERO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERO vs. The Competition Export to ExcelMetricVenus ConceptMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.49M$6.82B$5.75B$9.62BDividend YieldN/A1.31%4.40%4.10%P/E Ratio-0.0527.4531.2526.05Price / Sales0.0675.47433.91193.97Price / CashN/A21.3437.7358.48Price / Book1.266.889.536.61Net Income-$47M$176.42M$3.26B$265.65M7 Day Performance5.60%1.45%2.13%2.03%1 Month Performance-2.00%-2.71%2.80%-0.31%1 Year Performance-62.81%9.40%30.68%19.06% Venus Concept Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VEROVenus Concept0.3736 of 5 stars$2.45+0.8%N/A-61.9%$3.49M$60.11M-0.05410News CoverageGap DownNXLNexalin Technology2.4501 of 5 stars$0.80-0.6%$5.00+525.0%+6.8%$13.40M$170K-1.013Gap UpMHUAMeihua International Medical Technologies0.3786 of 5 stars$0.40-0.7%N/A-42.1%$12.79M$96.90M0.00620News CoverageShort Interest ↑TNONTenon Medical1.5465 of 5 stars$1.44+1.4%$5.50+281.9%+178.5%$12.79M$3.28M-0.058Gap DownXAIRBeyond Air3.8763 of 5 stars$2.31-3.8%$11.00+376.2%-73.4%$12.11M$3.70M-0.1970News CoverageAnalyst ForecastShort Interest ↑LYRALyra Therapeutics3.2367 of 5 stars$7.08-3.1%$100.00+1,312.4%-52.9%$11.61M$1.53M-0.2450Positive NewsOSRHOSRN/A$0.55-2.2%N/AN/A$10.60MN/A0.00N/APositive NewsGap UpINBSIntelligent Bio Solutions0.3468 of 5 stars$1.51+0.7%N/A+30.4%$10.54M$3.05M-0.7410Earnings ReportCODXCo-Diagnostics4.4193 of 5 stars$0.30-5.3%$5.50+1,715.2%-79.4%$10.11M$3.91M-0.26100News CoverageShort Interest ↓Analyst RevisionPOAIPredictive Oncology0.5109 of 5 stars$0.89+4.3%$3.00+237.1%-2.1%$9.69M$1.66M-0.2930News CoverageGap UpLUCYInnovative Eyewear0.5171 of 5 stars$1.99-1.7%N/A-46.2%$9.07M$1.64M-0.719Short Interest ↓ Related Companies and Tools Related Companies NXL Alternatives MHUA Alternatives TNON Alternatives XAIR Alternatives LYRA Alternatives OSRH Alternatives INBS Alternatives CODX Alternatives POAI Alternatives LUCY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERO) was last updated on 8/23/2025 by MarketBeat.com Staff From Our PartnersBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredTrump set to Boost Social Security Checks by 400%?If you're collecting or planning to collect social security... You should see this presentation about Presi...InvestorPlace | SponsoredOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access